Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure.

@article{Devasia2009FluoroquinoloneRI,
  title={Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure.},
  author={Rose A. Devasia and Amondrea Blackman and Tebeb Gebretsadik and Marie Griffin and Ayumi Shintani and Carolyn May and Teresa Rust Smith and Nancy Hooper and Fernanda Maruri and Jon V. Warkentin and Ed Mitchel and Timothy R. Sterling},
  journal={American journal of respiratory and critical care medicine},
  year={2009},
  volume={180 4},
  pages={365-70}
}
RATIONALE Fluoroquinolones are the most commonly prescribed antibiotic class in the United States. They have the potential to become first-line antituberculosis therapy, but the effect of fluoroquinolone use on fluoroquinolone resistance in Mycobacterium tuberculosis is not well characterized. OBJECTIVES To determine the prevalence of and risk factors for fluoroquinolone-resistant tuberculosis in a large United States population. METHODS We identified all people with culture-confirmed… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 53 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 19 references

Trends in fluoroquinolone resistance and exposure in newly diagnosed tuberculosis: 2002–2006 [abstract

  • R Devasia, M Griffin, +5 authors E. Mitchel
  • Am J Respir Crit Care Med 2008;177:A19
  • 2008
1 Excerpt

A randomized placebocontrolled trial of moxifloxacin vs. Ethambutol in the initial phase of tuberculosis therapy in Brazil

  • RE Chaisson, M Conde, A Efron, C. Loredo
  • Interscience Conference of Antimicrobial Agents…
  • 2007

Similar Papers

Loading similar papers…